Ovid Therapeutics Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Ovid Therapeutics Inc. (OVID) is 480.84M

According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 480.84M. This represents a change of 292.68% compared to the average of 122.45M of the last 4 quarters.

Ovid Therapeutics Inc. (OVID) Historical Enterprise Value (quarterly & annually)

How has OVID Enterprise Value performed in the past?

The mean historical Enterprise Value of Ovid Therapeutics Inc. over the last ten years is 102.18M. The current 480.84M Enterprise Value has changed 370.61% with respect to the historical average. Over the past ten years (40 quarters), OVID's Enterprise Value was at its highest in in the June 2020 quarter at 364.12M. The Enterprise Value was at its lowest in in the March 2019 quarter at -1219281.00.

Ovid Therapeutics Inc. (OVID) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ovid Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ovid Therapeutics Inc. (OVID) Average Enterprise Value

How has OVID Enterprise Value performed in the past?

The current Enterprise Value of Ovid Therapeutics Inc. (OVID) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ovid Therapeutics Inc. (OVID) Enterprise Value vs. Peers

How is OVID’s Enterprise Value compared to its peers?

Ovid Therapeutics Inc.’s Enterprise Value is greater than Rocket Pharmaceuticals, Inc. (67.59M), less than Stoke Therapeutics, Inc. (1.58B), less than Ultragenyx Pharmaceutical Inc. (2.66B), less than Wave Life Sciences Ltd. (546.12M), less than MeiraGTx Holdings plc (866.08M), greater than Neurogene Inc. (330.62M), less than Taysha Gene Therapies, Inc. (924.34M), greater than Lexeo Therapeutics, Inc. Common Stock (168.86M), greater than Voyager Therapeutics, Inc. (104.63M), greater than Abeona Therapeutics Inc. (204.10M),

Build a custom stock screener for Ovid Therapeutics Inc. (OVID) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ovid Therapeutics Inc. (OVID) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.